 |
Phase II-III Trials DRC can collect patients from the following therapeutic areas: Cardiovascular Diseases, Diabetes, Osteoporosis, Musculoskeletal diseases, Hyperlipidemia, Obesity; Hypertension, Asthma, COPD, chronic and acute bronchitis and tumors The attached reference list demonstrates the international acceptance of DRC’s Phase II-III activities. |
|